Search research articles
Contact Us
Filters
Showing results (621-630 of 688) with videos related to
Page
of 69
Sort By:
The Lancet. Oncology
|
February 19, 2020
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial
Javier Martin-Broto, Josefina Cruz, Nicolas Penel, et al.
Breast Cancer Research and Treatment
|
February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses
E Palassini, O Mir, G Grignani, et al.
Annals of Surgical Oncology
|
April 28, 2021
Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Cancer
|
March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Lorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2019
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Chandrajit P Raut, Dario Callegaro, Rosalba Miceli, et al.
Annals of Surgical Oncology
|
January 3, 2021
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)
Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Pediatric Blood & Cancer
|
January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial
Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
David S Moura, Jesus M Lopez-Marti, Iva Benesova, et al.
JAMA Network Open
|
November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial
Sandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Cancer Communications (London, England)
|
March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort
Javier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Page
of 69
Search research articles
Search
Showing results (621-630 of 688) with videos related to
Sort By:
Page
of 69
The Lancet. Oncology
|
February 19, 2020
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial
Javier Martin-Broto, Josefina Cruz, Nicolas Penel, et al.
Breast Cancer Research and Treatment
|
February 12, 2022
Systemic treatment in advanced phyllodes tumor of the breast: a multi-institutional European retrospective case-series analyses
E Palassini, O Mir, G Grignani, et al.
Annals of Surgical Oncology
|
April 28, 2021
Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Cancer
|
March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Lorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2019
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Chandrajit P Raut, Dario Callegaro, Rosalba Miceli, et al.
Annals of Surgical Oncology
|
January 3, 2021
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)
Carolyn Nessim, Chandrajit P Raut, Dario Callegaro, et al.
Pediatric Blood & Cancer
|
January 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial
Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
David S Moura, Jesus M Lopez-Marti, Iva Benesova, et al.
JAMA Network Open
|
November 6, 2025
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial
Sandro Pasquali, Paola Collini, Cleofe Romagosa, et al.
Cancer Communications (London, England)
|
March 16, 2026
IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort
Javier Martin-Broto, Sandra J Strauss, Emanuela Palmerini, et al.
Page
of 69